RUN vs UTHR · P/E 6.0, rev $2.04B vs P/E 20, rev $2.88B
Sunrun Inc (RUN) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Latest reported UTHR revenue for 2024-12-31 was $2.88B. Net income was $1.20B. Revenue was up 23.6% from 2023-12-31 to 2024-12-31. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
RUN currently screens at market cap $3.05B and trailing P/E 6.0. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the RUN and UTHR stock pages for the full models.
Not investment advice.